AssayIndex
Reports by quarter

Reports submitted in 2026-Q3 · page 12

Quarter in progress. Aggregates for this quarter are provisional. Median purity for the quarter is 98.92 % area, n=453. Read the 2026-Q3 state-of-the-index report →

453 records12 pagesmedian on this page 98.77 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-042213LL-37HomopeptideHOMO-2602-G1280Janoshik2026-Q399.065.98100.5Supplier-supplied1MARGINAL
AX-2026-041959TirzepatideTFCTFC-2605-G5134Janoshik2026-Q398.697.22105.9Supplier-supplied2MARGINAL
AX-2026-041893HexarelinJEEPJEEP-2608-Y4367PeptideMeter2026-Q399.443.58103.2Supplier-supplied0PASS
AX-2026-041382BPC-157WWBWWB-2606-H3906Janoshik2026-Q399.904.95—Supplier-supplied1MARGINAL
AX-2026-042660CJC-1295 (no DAC)GGPepsGGPE-2606-E8495PeptideMeter2026-Q397.883.38—Supplier-supplied1FAIL
AX-2026-042549SurvodutideERPERP-2605-E7682Janoshik2026-Q398.735.5191.2Supplier-supplied1MARGINAL
AX-2026-041729CJC-1295 with DACQSCQSC-2602-E9474Nordanalyt2026-Q399.277.23104.7Supplier-supplied1MARGINAL
AX-2026-041428IpamorelinQYBQYB-2605-H4298Janoshik2026-Q399.933.85106.9Supplier-supplied2FAIL
AX-2026-043036RetatrutideKPKP-2607-H5219Janoshik2026-Q395.675.8594.5Buyer-sourced2FAIL
AX-2026-042218LL-37HomopeptideHOMO-2602-G1280Janoshik2026-Q399.585.94104.1Supplier-supplied0PASS
AX-2026-043313TirzepatideCPCCPC-2607-L2552Kestrel2026-Q398.165.32—Supplier-supplied2MARGINAL
AX-2026-041535RetatrutideQYBQYB-2602-G6308Janoshik2026-Q398.773.47—Supplier-supplied2MARGINAL
AX-2026-042664CJC-1295 (no DAC)GGPepsGGPE-2606-E8495Nordanalyt2026-Q397.753.84—Buyer-sourced1FAIL